# Community Healthcare Trust Inc: financial statements, quarterly

CHCT · NYSE · CIK 1631569 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chct.md) · [Financials](/companies/chct/financials.md) · [Filings](/companies/chct/filings.md) · [Insiders](/companies/chct/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chct/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [28.7](/filings/0001631569-24-000101.md) | [29.1 d](/filings/0001631569-26-000012.md) | [29.3](/filings/0001631569-25-000030.md) | [27.5](/filings/0001628280-25-036446.md) | [29.6](/filings/0001631569-25-000091.md) | [29.3 d](/filings/0001631569-26-000012.md) | [30.1](/filings/0001631569-26-000026.md) | [29.1](/filings/0001631569-26-000038.md) | [31.1](/filings/0001631569-25-000091.md) | [30.9 d](/filings/0001631569-26-000012.md) | [31.5](/filings/0001631569-26-000026.md) | [31.2](/filings/0001631569-26-000038.md) |
| Interest expense | $m | [4.6](/filings/0001631569-23-000103.md) | [5.0 d](/filings/0001631569-24-000024.md) | [5.1](/filings/0001631569-24-000042.md) | [6.0](/filings/0001628280-25-036446.md) | [6.3](/filings/0001631569-25-000091.md) | [6.4 d](/filings/0001631569-26-000012.md) | [6.4](/filings/0001631569-26-000026.md) | [6.6](/filings/0001631569-26-000038.md) | [7.1](/filings/0001631569-25-000091.md) | [7.0 d](/filings/0001631569-26-000012.md) | [6.8](/filings/0001631569-26-000026.md) | [7.4](/filings/0001631569-26-000038.md) |
| Net income | $m | [3.5](/filings/0001631569-24-000101.md) | [4.6 d](/filings/0001631569-26-000012.md) | [3.7](/filings/0001631569-25-000030.md) | [(10.4)](/filings/0001628280-25-036446.md) | [1.7](/filings/0001631569-25-000091.md) | [1.8 d](/filings/0001631569-26-000012.md) | [1.6](/filings/0001631569-26-000026.md) | [(12.6)](/filings/0001631569-26-000038.md) | [1.6](/filings/0001631569-25-000091.md) | [14.4 d](/filings/0001631569-26-000012.md) | [2.5](/filings/0001631569-26-000026.md) | [2.4](/filings/0001631569-26-000038.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001631569-24-000101.md) | not reported | [0.11](/filings/0001631569-25-000030.md) | [(0.42)](/filings/0001628280-25-036446.md) | [0.04](/filings/0001631569-25-000091.md) | not reported | [0.03](/filings/0001631569-26-000026.md) | [(0.50)](/filings/0001631569-26-000038.md) | [0.03](/filings/0001631569-25-000091.md) | not reported | [0.07](/filings/0001631569-26-000026.md) | [0.06](/filings/0001631569-26-000038.md) |
| Basic EPS | $ per share | [0.11](/filings/0001631569-24-000101.md) | not reported | [0.11](/filings/0001631569-25-000030.md) | [(0.42)](/filings/0001628280-25-036446.md) | [0.04](/filings/0001631569-25-000091.md) | not reported | [0.03](/filings/0001631569-26-000026.md) | [(0.50)](/filings/0001631569-26-000038.md) | [0.03](/filings/0001631569-25-000091.md) | not reported | [0.07](/filings/0001631569-26-000026.md) | [0.06](/filings/0001631569-26-000038.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.9](/filings/0001631569-24-000101.md) | [3.5](/filings/0001631569-25-000015.md) | [3.8](/filings/0001631569-25-000030.md) | [0.7](/filings/0001631569-24-000077.md) | [2.8](/filings/0001631569-24-000101.md) | [4.4](/filings/0001631569-26-000012.md) | [2.3](/filings/0001631569-25-000030.md) | [4.9](/filings/0001628280-25-036446.md) | [3.4](/filings/0001631569-25-000091.md) | [3.3](/filings/0001631569-26-000038.md) | [2.6](/filings/0001631569-26-000026.md) | [2.7](/filings/0001631569-26-000038.md) |
| Total assets | $m | [955](/filings/0001631569-23-000103.md) | [945](/filings/0001631569-25-000015.md) | [983](/filings/0001631569-24-000042.md) | [983](/filings/0001631569-24-000077.md) | [982](/filings/0001631569-24-000101.md) | [993](/filings/0001631569-26-000012.md) | [985](/filings/0001631569-25-000030.md) | [966](/filings/0001628280-25-036446.md) | [987](/filings/0001631569-25-000091.md) | [991](/filings/0001631569-26-000038.md) | [1,010](/filings/0001631569-26-000026.md) | [1,004](/filings/0001631569-26-000038.md) |
| Total liabilities | $m | [433](/filings/0001631569-23-000103.md) | [432](/filings/0001631569-25-000015.md) | [471](/filings/0001631569-24-000042.md) | [485](/filings/0001631569-24-000077.md) | [505](/filings/0001631569-24-000101.md) | [517](/filings/0001631569-26-000012.md) | [524](/filings/0001631569-25-000030.md) | [528](/filings/0001628280-25-036446.md) | [560](/filings/0001631569-25-000091.md) | [561](/filings/0001631569-26-000038.md) | [589](/filings/0001631569-26-000026.md) | [589](/filings/0001631569-26-000038.md) |
| Long-term debt | $m | [401](/filings/0001631569-23-000103.md) | [403](/filings/0001631569-25-000015.md) | [442](/filings/0001631569-24-000042.md) | [458](/filings/0001631569-24-000077.md) | [474](/filings/0001631569-24-000101.md) | [486](/filings/0001631569-26-000012.md) | [496](/filings/0001631569-25-000030.md) | [500](/filings/0001628280-25-036446.md) | [530](/filings/0001631569-25-000091.md) | [532](/filings/0001631569-26-000038.md) | [559](/filings/0001631569-26-000026.md) | [559](/filings/0001631569-26-000038.md) |
| Shareholders' equity | $m | [522](/filings/0001631569-23-000103.md) | [513](/filings/0001631569-25-000015.md) | [512](/filings/0001631569-24-000042.md) | [498](/filings/0001631569-24-000077.md) | [477](/filings/0001631569-24-000101.md) | [476](/filings/0001631569-26-000012.md) | [461](/filings/0001631569-25-000030.md) | [438](/filings/0001628280-25-036446.md) | [427](/filings/0001631569-25-000091.md) | [429](/filings/0001631569-26-000038.md) | [421](/filings/0001631569-26-000026.md) | [414](/filings/0001631569-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.7 d](/filings/0001631569-24-000101.md) | [14.3 d](/filings/0001631569-26-000012.md) | [12.6](/filings/0001631569-25-000030.md) | [16.7 d](/filings/0001628280-25-036446.md) | [13.8 d](/filings/0001631569-25-000091.md) | [15.7 d](/filings/0001631569-26-000012.md) | [14.4](/filings/0001631569-26-000026.md) | [13.8 d](/filings/0001631569-26-000038.md) | [12.7 d](/filings/0001631569-25-000091.md) | [15.5 d](/filings/0001631569-26-000012.md) | [13.7](/filings/0001631569-26-000026.md) | [17.5 d](/filings/0001631569-26-000038.md) |
| Dividends paid | $m | [12.1 d](/filings/0001631569-24-000101.md) | [12.4 d](/filings/0001631569-26-000012.md) | [12.7](/filings/0001631569-25-000030.md) | [12.8 d](/filings/0001628280-25-036446.md) | [13.1 d](/filings/0001631569-25-000091.md) | [13.1 d](/filings/0001631569-26-000012.md) | [13.3](/filings/0001631569-26-000026.md) | [13.4 d](/filings/0001631569-26-000038.md) | [13.5 d](/filings/0001631569-25-000091.md) | [13.5 d](/filings/0001631569-26-000012.md) | [13.7](/filings/0001631569-26-000026.md) | [13.8 d](/filings/0001631569-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.6](/filings/0001631569-23-000103.md) | [24.2](/filings/0001631569-24-000042.md) | [25.1](/filings/0001631569-24-000077.md) | [25.5](/filings/0001631569-24-000101.md) | [26.3](/filings/0001631569-25-000030.md) | [26.5](/filings/0001628280-25-036446.md) | [26.7](/filings/0001631569-25-000091.md) | [26.7](/filings/0001631569-26-000026.md) | [26.8](/filings/0001631569-26-000038.md) | [26.9](/filings/0001631569-25-000091.md) | [27.0](/filings/0001631569-26-000026.md) | [27.0](/filings/0001631569-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,653,842 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001631569-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.